Skip to main content

Sofwave Participate in LifeSci Partners HealthTech Symposium

Written by Customer Service on . Posted in Public Companies.

  • Virtual fireside chat to take place on Wednesday, September 21, 2022 at 11:00 a.m. ET

SAN CLEMENTE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, will participate in a medical aesthetics fireside chat at the virtual LifeSci Partners HealthTech Symposium on Wednesday, September 21, 2022 at 11:00 a.m. ET.

For more information or to register for the 2 day event being held from September 20-21, please visit: https://lifescievents.com/event/healthtech-symposium.

Live and archived webcasts of the fireside chat and panel discussion will be available on the Investors section of Sofwave’s website prior to the start of the event at: https://sofwave.com/investors.

LifeSci Partners HealthTech Symposium will be a virtual event, highlighting public/private digital health and medtech companies that are driving change across virtually every aspect of healthcare.

Given the pace of technological innovation occurring today, we are seeing an unprecedented number of products and services coming to market with the intention of further improving outcomes in a scalable and cost-effective manner. In parallel, we are seeing greater adoption of healthcare technologies by patients and providers and greater urgency from regulators to lower many of the barriers that have historically hindered the development and commercialization of these innovative solutions. Now more than ever, we believe the broader healthcare technology sector is ripe for innovation and is on the precipice of its next great transformation. As such, LifeSci Partners is pleased to host a selection of some of the most promising health tech companies, who will have the opportunity to present to our extensive global network of investors and potential strategic partners.

About Sofwave Medical
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction and lifting using proprietary breakthrough technology. Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
britchie@lifesciadvisors.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.